An Innovative Unbound Bilirubin Assay to Identify Bilirubin-Induced Neurological Dysfunction (BIND) Risk as Part of a Comprehensive and Novel Point-of-Care Newborn Screening Panel

Information

  • Research Project
  • 10127691
  • ApplicationId
    10127691
  • Core Project Number
    R44HL146016
  • Full Project Number
    5R44HL146016-03
  • Serial Number
    146016
  • FOA Number
    PA-18-574
  • Sub Project Id
  • Project Start Date
    7/1/2019 - 5 years ago
  • Project End Date
    3/31/2022 - 2 years ago
  • Program Officer Name
    WARREN, RONALD Q
  • Budget Start Date
    4/1/2021 - 3 years ago
  • Budget End Date
    3/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    03
  • Suffix
  • Award Notice Date
    3/23/2021 - 3 years ago
Organizations

An Innovative Unbound Bilirubin Assay to Identify Bilirubin-Induced Neurological Dysfunction (BIND) Risk as Part of a Comprehensive and Novel Point-of-Care Newborn Screening Panel

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R44
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    681054
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    839
  • Ed Inst. Type
  • Funding ICs
    NHLBI:681054\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    BAEBIES, INC.
  • Organization Department
  • Organization DUNS
    079264306
  • Organization City
    DURHAM
  • Organization State
    NC
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    277094403
  • Organization District
    UNITED STATES